Hormone receptors AR, ER, PR and growth factor receptor Her-2 expression in oral squamous cell carcinoma: Correlation with overall survival, disease-free survival and 10-year survival in a high-risk population.

PLoS One · 2022 · PMC9094515 · PMID 35544472

Europe PMC DOI

hedged sentences

0.0720

closest p · 1.4× alpha

0.0920

boldest claim

The sentences

borderline significantP = 0.072so close (0.05 < p ≤ 0.1)

Based on biomarker expression, AR positive patients had DFS of 122 months while negative patients had shorter DFS of 45 months, but this was borderline significant ( P = 0.072).

also in 11,409 other papers

did not reach statistical significanceP = 0.092so close (0.05 < p ≤ 0.1)

While the DFS was also lower for Her-2 strong positive cases at median 21 months as compared to 52 months for Her-2 negative patients, this did not reach statistical significance ( P = 0.092).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.